×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [ecog ps]
Stereotactic Ablative RT in HCC
958 views
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO conference
377 views
A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid Tumors Anthony W. Tolcher, 1 Timothy A. Yap, 2 Ivy
217 views
Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives Moderator: Ashley Grossman, MD, FRCP Professor of Neuroendocrinology
219 views
II-SDV 2014 Development of Reports and Visualisations to Facilitate the Analysis and Transformation of the Clinical Trial Landscape into Actionable Intelligence (Diane Webb - Bizint,
480 views
Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
1.428 views
07 state of the art of the management of advanced and recurrent ovarian cancer
443 views
Pfizer at Lehman Brothers Global Health Care Conference
1.022 views
FOLFOXIRI plus bevacizumab (bev) vs FOLFIRI plus bev as 1st-line treatment of metastatic colorectal cancer: results of the phase III randomized TRIBE trial
219 views
1. DLBCL of the elderly in age older than life expectancy the single institute experience in Taiwan Sheng Hsuan,Chien, MD Division of Hematology and Oncology,
217 views
A pooled analysis of the final results of the two randomized phase II studies comparing Gemcitabine (G) vs Gemcitabine + Docetaxel (G+D) in patients (pts)
219 views
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
220 views
Next >